Nouscom AG

The biopharma sectors in Europe and China could be hard hit by President Trump’s policies aimed at incentivizing investment in the US, with big pharma already rushing to highlight their stateside comm

Two new venture capital funds based outside of the US together offer $365m for life science start-ups, including Amplitude Ventures’ second fund and XGEN Venture’s inaugural fund. Montreal-based Ampli

Capstan Therapeutics Inc. and Engrail Therapeutics are among the latest companies to raise venture capital mega-rounds of $100m or more as the deluge of large private financings early in 2024 coinc

Marina Udier faces a challenging task as CEO of NousCom AG , a Basel, Switzerland-based biotech developing neoantigen-based vaccines. While the concept has been around for years without significant c